|
Istradefylline Approved for Parkinson Add-On Therapy
|
|
After being approved in Japan in 2013, the selective adenosine A 2A receptor antagonist was given the OK as an add-on to levodopa/carbidopa treatment in adults with Parkinson disease. |
|
Read more
|
|
|
| Experts to Discuss Central Issues in Stroke Care at Future of Neurology Congress |
|
This Fall, top neurology professionals will convene in New York City for the 1st annual International Congress on the Future of Neurology, held September 27-28, 2019 at the InterContinental New York Times Square. |
|
Read more
|
|
|
